-
CYP2D6 genetic polymorphism and genetic ancestry on extrapyramidal side-effects of long-term treatment with classical antipsychotics in cuban patients with schizophrenia
Hilda Roblejo Balbuena, Beatriz Marcheco Teruel, Salvador González Pal, Toro Bordado, Ivette Camayd Viera, Giselle Monzón Benítez, Lilia C Marín Padrón, Adrián Llerena Ruíz
Research Article: Clinical Investigation
-
CYP2D6 genetic polymorphism and genetic ancestry on extrapyramidal side-effects of long-term treatment with classical antipsychotics in cuban patients with schizophrenia
Hilda Roblejo Balbuena, Beatriz Marcheco Teruel, Salvador González Pal, Toro Bordado, Ivette Camayd Viera, Giselle Monzón Benítez, Lilia C Marín Padrón, Adrián Llerena Ruíz
Research Article: Clinical Investigation
-
CYP2D6 genetic polymorphism and genetic ancestry on extrapyramidal side-effects of long-term treatment with classical antipsychotics in cuban patients with schizophrenia
Hilda Roblejo Balbuena, Beatriz Marcheco Teruel, Salvador González Pal, Toro Bordado, Ivette Camayd Viera, Giselle Monzón Benítez, Lilia C Marín Padrón, Adrián Llerena Ruíz
Research Article: Clinical Investigation
-
CYP2D6 genetic polymorphism and genetic ancestry on extrapyramidal side-effects of long-term treatment with classical antipsychotics in cuban patients with schizophrenia
Hilda Roblejo Balbuena, Beatriz Marcheco Teruel, Salvador González Pal, Toro Bordado, Ivette Camayd Viera, Giselle Monzón Benítez, Lilia C Marín Padrón, Adrián Llerena Ruíz
Research Article: Clinical Investigation
-
CYP2D6 genetic polymorphism and genetic ancestry on extrapyramidal side-effects of long-term treatment with classical antipsychotics in cuban patients with schizophrenia
Hilda Roblejo Balbuena, Beatriz Marcheco Teruel, Salvador González Pal, Toro Bordado, Ivette Camayd Viera, Giselle Monzón Benítez, Lilia C Marín Padrón, Adrián Llerena Ruíz
Research Article: Clinical Investigation
-
CYP2D6 genetic polymorphism and genetic ancestry on extrapyramidal side-effects of long-term treatment with classical antipsychotics in cuban patients with schizophrenia
Hilda Roblejo Balbuena, Beatriz Marcheco Teruel, Salvador González Pal, Toro Bordado, Ivette Camayd Viera, Giselle Monzón Benítez, Lilia C Marín Padrón, Adrián Llerena Ruíz
Research Article: Clinical Investigation
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Anti-MET Targeted therapy for NSCLC: has it come of age?
Patrick C Ma
Editorial: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence of the role of edoxaban in anticoagulation
Elena Fortuny ,Jose Zamorano
Review: Clinical Trail Outcomes: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation
-
New oral anticoagulants for stroke prevention in atrial fibrillation
John W Eikelboom, Jeffrey I Weitz
Editorial: Clinical Investigation